Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

173 search results for ‘*’

Discovery & Development Drug Delivery

Squid-Inspired Drug Delivery

| Stephanie Vine | 4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally.

Discovery & Development Drug Discovery

Antibiotics: Going With the Flow

| Rob Coker | 2 min read

How fluid flow through the body can affect the ways in which antibiotics work.

Business & Regulation Standards & Regulation

Peter Marks Resigns from FDA

| Stephanie Vine | 3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr.

Business & Regulation Standards & Regulation

Vaccines and Autism: Perpetuating a Populist Agenda

| Rob Coker | 3 min read

Rumours claim that a well-known vaccine skeptic has been appointed to lead study on links between vaccines and autism.

Business & Regulation Business Practice

Calling Out Misleading Information

| Rob Coker | 2 min read

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

Business & Regulation Standards & Regulation

GSK’s Flovent Strategy Under Federal Scrutiny?

| Rob Coker | 2 min read

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Discovery & Development Drug Discovery

Hail to the Hardy Tardigrade

| Rob Coker | 2 min read

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Discovery & Development Dosage Forms

Co-Crystals Shine in Innovation Awards

| 1 min read

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction.

Discovery & Development Drug Discovery

Fixing Faulty Splicing

| Stephanie Vine | 2 min read

How antisense oligonucleotides open up targeted approaches to rare disease treatment.

Discovery & Development Drug Delivery

RIDE: A New Approach to CRISPR Delivery

| Rob Coker | 2 min read

A new study reports targeted CRISPR delivery in retinal and neurological disease models – without viral vectors.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker